There are currently no known outstanding effects for the Medicines and Medical Devices Act 2021, Section 14.
(1)In this Part—
“active substance” means any substance or mixture of substances intended to be used in the manufacture of a veterinary medicine that, when used in its production, becomes an active ingredient of that medicine;
“appropriate authority” has the meaning given by section 10(6);
“manufacture” includes assembly;
“marketing authorisation” means an authorisation to market a veterinary medicine in the United Kingdom;
“veterinary medicine” means a veterinary medicinal product within the meaning given by regulation 2 of the Veterinary Medicines Regulations 2013 (S.I. 2013/2033).
(2)In the Animals (Scientific Procedures) Act 1986, in section 2 (regulated procedures), in subsection (8)(d), after “the Veterinary Medicines Regulations 2011” insert “ or the Veterinary Medicines Regulations 2013 ”.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
